Ticker Appearances
Signal From Noise
The AI Play in Pharmaceuticals
After the past few years of AI hype and capital expenditure, investor attention is increasingly on concrete, real-world benefits of this new technology – both...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2026
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Bonds, Gold, Yen all about to rally
SHORT-TERM TRENDS IN US EQUITIES REMAIN BULLISH, AND SPX HAS NOW TURNED POSITIVE FOR THE YEAR AFTER HAVING RISEN OVER 1000 POINTS OFF THE 4/7/25...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare on the verge of breaking out to new All-time highs on an Equal-weighted basis
THE RECENT STALLING OUT IN MOST US EQUITY INDICES OVER THE LAST WEEK HASN’T TAKEN AWAY FROM THE APPEAL OF THE CURRENT RALLY FROM EARLY...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Signal From Noise
Daily Technical Strategy
Upticks - August 2023
UPTICKS LAGGARDS MEANINGFUL MOVEMENT WORTH DISCUSSING AMONG CURRENT UPTICKS HOLDINGS BOSTON SCIENTIFIC (BSX -1.33% - $53.95) Source: Trading View BOSTON SCIENTIFIC (BSX -1.33% - $53.95) was added to my...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Defensive trading dominates as Pharma, & Utilities break out
Similar to Tuesday’s mild “down day,” Wednesday’s pullback failed to show sufficient deterioration to expect much follow-through just yet. The key driver of this rally,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare springs to life as Financials nose-dive
The SPX’s near-term decline is ongoing, regardless of some brief stabilization attempts on Monday. While US indices are now in the window for a possible...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
LIVE Technical Stock Analysis March 2023
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare should soon hit support and reverse in February
January’s strong gains suggest that the bullish Pre-election year seasonality trends likely outweigh the bearish forecasts about how dismal earnings should be, and the NASDAQ...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Signal From Noise
The AI Play in Pharmaceuticals
After the past few years of AI hype and capital expenditure, investor attention is increasingly on concrete, real-world benefits of this new technology – both...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2026
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Bonds, Gold, Yen all about to rally
SHORT-TERM TRENDS IN US EQUITIES REMAIN BULLISH, AND SPX HAS NOW TURNED POSITIVE FOR THE YEAR AFTER HAVING RISEN OVER 1000 POINTS OFF THE 4/7/25...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare on the verge of breaking out to new All-time highs on an Equal-weighted basis
THE RECENT STALLING OUT IN MOST US EQUITY INDICES OVER THE LAST WEEK HASN’T TAKEN AWAY FROM THE APPEAL OF THE CURRENT RALLY FROM EARLY...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Signal From Noise
Daily Technical Strategy
Upticks - August 2023
UPTICKS LAGGARDS MEANINGFUL MOVEMENT WORTH DISCUSSING AMONG CURRENT UPTICKS HOLDINGS BOSTON SCIENTIFIC (BSX -1.33% - $53.95) Source: Trading View BOSTON SCIENTIFIC (BSX -1.33% - $53.95) was added to my...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Defensive trading dominates as Pharma, & Utilities break out
Similar to Tuesday’s mild “down day,” Wednesday’s pullback failed to show sufficient deterioration to expect much follow-through just yet. The key driver of this rally,...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare springs to life as Financials nose-dive
The SPX’s near-term decline is ongoing, regardless of some brief stabilization attempts on Monday. While US indices are now in the window for a possible...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Technical Strategy
LIVE Technical Stock Analysis March 2023
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare should soon hit support and reverse in February
January’s strong gains suggest that the bullish Pre-election year seasonality trends likely outweigh the bearish forecasts about how dismal earnings should be, and the NASDAQ...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis - February 2026
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Bonds, Gold, Yen all about to rally
SHORT-TERM TRENDS IN US EQUITIES REMAIN BULLISH, AND SPX HAS NOW TURNED POSITIVE FOR THE YEAR AFTER HAVING RISEN OVER 1000 POINTS OFF THE 4/7/25...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
Daily Technical Strategy
Healthcare on the verge of breaking out to new All-time highs on an Equal-weighted basis
THE RECENT STALLING OUT IN MOST US EQUITY INDICES OVER THE LAST WEEK HASN’T TAKEN AWAY FROM THE APPEAL OF THE CURRENT RALLY FROM EARLY...
This report is accessible to Fundstrat Pro & Fundstrat Macro memberships.
You have viewed the limit of 2 Macro reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In unknown
Visitor: unknown Array ( [current_usage] => 2 [current_usage_crypto] => 1 [max_usage] => 2 [max_usage_crypto] => 2 )
